A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

Israeli researchers at a blood cancer conference in the US reported a lymphoma treatment that can achieve 100% survival rates ...

Lyell management will host an investor webcast with presenting author and ronde-cel investigator Sarah M. Larson, MD, ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

Patients in 200 mg BID cohort had median progression free survival of 6.2 months and median overall survival of 28.1 months, comparing favorably ...

In a head-to-head trial, Lilly’s drug was as effective as Imbruvica at inducing responses and displayed certain safety ...

Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...

There is a link between non-Hodgkin’s lymphoma (NHL) and smoking. Heavy smoking has an association with NHL, and the link is especially strong with the subtype known as follicular lymphoma. A 2017 ...